Northwest Biotherapeutics (NWBO) Payables (2010 - 2026)
Northwest Biotherapeutics' Payables was $42.78 million in Q2 2026, up 7.0% from $39.97 million a year earlier but down 1.1% from the prior quarter.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Payables at Northwest Biotherapeutics came in at $40.28 million, up 29.3% from FY2024.
- Payables shows a five-year compound annual growth rate of 32.6% (FY2020 to FY2025).
- In earlier years, Payables was $31.16 million in FY2024 (+119.6%), $14.19 million in FY2023 (-45.6%), $26.09 million in FY2022 (+85.3%) and $14.08 million in FY2021 (+43.4%).
- Quarterly Payables has moved between $14.08 million (Q4 2021) and $43.23 million (Q1 2026) over five years.
- Compared with a year earlier, Payables has increased for ten straight quarters, with growth averaging 45.1% over the last eight quarters.
- The best year-over-year quarter for Payables over five years was Q4 2024 (growth of 119.6%); the worst was Q4 2023 (a decline of 45.6%).
- Per Business Quant data, NWBO's Payables in the three quarters before Q2 2026 was $43.23 million (Q1 2026), $40.28 million (Q4 2025) and $40.45 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Northwest Biotherapeutics | 250.40 Mn | 240.41 Mn | - | 42.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.78 Mn |
| Mar 31, 2026 | 43.23 Mn |
| Dec 31, 2025 | 40.28 Mn |
| Sep 30, 2025 | 40.45 Mn |
| Jun 30, 2025 | 39.97 Mn |
| Mar 31, 2025 | 40.39 Mn |
| Dec 31, 2024 | 31.16 Mn |
| Sep 30, 2024 | 25.49 Mn |
| Jun 30, 2024 | 24.02 Mn |
| Mar 31, 2024 | 27.21 Mn |
| Dec 31, 2023 | 14.19 Mn |
| Sep 30, 2023 | 20.53 Mn |
| Jun 30, 2023 | 20.51 Mn |
| Mar 31, 2023 | 22.36 Mn |
| Dec 31, 2022 | 26.09 Mn |
| Sep 30, 2022 | 28.27 Mn |
| Jun 30, 2022 | 18.23 Mn |
| Mar 31, 2022 | 19.71 Mn |
| Dec 31, 2021 | 14.08 Mn |
| Sep 30, 2021 | 17.21 Mn |
API Access
Northwest Biotherapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=NWBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "NWBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=NWBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();